Peer Reviewed
Drug update
Budesonide/eformoterol combination inhaler as maintenance and reliever treatment in asthma
Abstract
For patients with significant asthma, the use of budesonide/eformoterol as both maintenance and reliever treatment is similarly effective to other management strategies in the achievement of good asthma control, while also reducing episodes of poor control and lessening overall treatment burden.
Key Points
There is now convincing evidence that the combination inhaler (budesonide/eformoterol) can be used as both maintenance and reliever therapy in patients with asthma, improving symptom control and lung function and reducing the risk of severe exacerbations.
Purchase the PDF version of this article
Already a subscriber? Login here.